Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated OsteosarcomaCompleted
NCT02517918Phase 1Updated Jun 8, 2025
Sponsor: Institut Bergonié
Solid Tumor · Osteosarcoma
France
Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)Completed
NCT03823794N/AUpdated Jun 6, 2025
Sponsor: Momentum Data
Atopic Dermatitis Eczema · Atopic Dermatitis · Eczema
United Kingdom
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)Recruiting
NCT05326620N/AUpdated Jun 6, 2025
Sponsor: PROspective Renal Cancer Cohort Foundation
Renal Cancer · Renal Cell Carcinoma · Renal Cell Cancer Metastatic
Netherlands
A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi ArabiaCompleted
NCT06016556N/AUpdated Jun 5, 2025
Sponsor: Pfizer
Covid-19
Saudi Arabia
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed ForcesCompleted
NCT06151418N/AUpdated Jun 4, 2025
Sponsor: Pfizer
Prostatic Neoplasms
United States
Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop RecorderCompleted
NCT02401854N/AUpdated Jun 4, 2025
Sponsor: Population Health Research Institute
Elderly · Hypertension · Risk Factors for Atrial Fibrillation
Canada
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompleted
NCT05796245N/AUpdated Jun 4, 2025
Sponsor: Pfizer
Arthritis, Rheumatoid · Colitis, Ulcerative · Crohn Disease · Psoriasis
Japan
A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes MellitusCompleted
NCT06279234Phase 1Updated Jun 3, 2025
Sponsor: Pfizer
Type 2 Diabetes Mellitus (T2DM) · Obesity
United States
A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIACompleted
NCT03000439Phase 3Updated Jun 3, 2025
Sponsor: Pfizer
Arthritis Juvenile Idiopathic
United States, Argentina, Belgium, Brazil, Canada +14 more
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast CancerTerminated
NCT04849364Phase 2Updated May 31, 2025
Sponsor: Bryan Schneider, MD
Breast Cancer · Triple Negative Breast Cancer
United States
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart ReviewCompleted
NCT04609319N/AUpdated May 31, 2025
Sponsor: Pfizer
Lung Cancer
China, India, Malaysia
Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in SpainRecruiting
NCT06991946N/AUpdated May 28, 2025
Sponsor: SOLTI Breast Cancer Research Group
Metastatic Breast Cancer
Spain
A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy AdultsCompleted
NCT06705569Phase 1Updated May 28, 2025
Sponsor: Pfizer
Healthy
Belgium
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.Terminated
NCT04152018Phase 1Updated May 28, 2025
Sponsor: Pfizer
Squamous Cell Carcinoma of the Head and Neck · Renal Cell Carcinoma · Ovarian Cancer · Gastric Cancer
United States, Australia, Slovakia, South Korea, Taiwan
A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy AdultsCompleted
NCT06645938Phase 1Updated May 25, 2025
Sponsor: Pfizer
Healthy
Belgium
A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy PeopleCompleted
NCT05411588Phase 1Updated May 25, 2025
Sponsor: Pfizer
Healthy Volunteers
United States, Belgium
To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy AdultsCompleted
NCT06593054Phase 1Updated May 21, 2025
Sponsor: Pfizer
Healthy
Belgium
Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in MaliCompleted
NCT04424511Phase 3Updated May 21, 2025
Sponsor: Tampere University
Mortality
Mali
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care TherapiesCompleted
NCT06592222N/AUpdated May 20, 2025
Sponsor: Pfizer
Multiple Myeloma
United States
Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast CancerCompleted
NCT06206239N/AUpdated May 20, 2025
Sponsor: Thomas Jefferson University
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma
United States
A Study to Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia PeopleCompleted
NCT05621239N/AUpdated May 20, 2025
Sponsor: Pfizer
COVID-19
Indonesia
Janus Kinase Inhibition in SarcoidosisCompleted
NCT05696795Phase 2Updated May 16, 2025
Sponsor: Yale University
Sarcoidosis
United States
Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaCompleted
NCT03472573Phase 1Updated May 15, 2025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Recurrent B Acute Lymphoblastic Leukemia · Refractory B Acute Lymphoblastic Leukemia
United States
Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)Completed
NCT04332744Phase 2Updated May 11, 2025
Sponsor: MedSIR
Metastatic Prostate Cancer
Spain
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or OlderCompleted
NCT05540522Phase 3Updated May 8, 2025
Sponsor: Pfizer
Influenza, Human
United States, Argentina, Chile, New Zealand, Philippines +1 more

Previous page Next page